BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 21 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $0 | – | 66 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |